Literature DB >> 2359062

Nifedipine versus ritodrine for suppressing preterm labor.

W R Meyer1, H W Randall, W L Graves.   

Abstract

Fifty-eight women in preterm labor were selected randomly to receive either oral nifedipine or intravenous ritodrine hydrochloride. In comparison to ritodrine, nifedipine had similar tocolytic efficacy with fewer adverse maternal and fetal side effects. On Doppler studies nifedipine had an insignificant effect on umbilical blood flow. Preliminary data suggest that nifedipine is a safe, effective and well-tolerated tocolytic agent. It may prove to be a suitable alternative to ritodrine hydrochloride, especially for women in whom beta-sympathomimetics are contraindicated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2359062

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  5 in total

1.  Nifedipine versus ritodrine for suppression of preterm labor and analysis of side effects.

Authors:  Purushottam Bankatlal Jaju; Veena B Dhabadi
Journal:  J Obstet Gynaecol India       Date:  2011-11-09

Review 2.  A risk-benefit assessment of therapies for premature labour.

Authors:  K Higby; C R Suiter
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

Review 3.  Calcium channel blockers for inhibiting preterm labour and birth.

Authors:  Vicki Flenady; Aleena M Wojcieszek; Dimitri N M Papatsonis; Owen M Stock; Linda Murray; Luke A Jardine; Bruno Carbonne
Journal:  Cochrane Database Syst Rev       Date:  2014-06-05

Review 4.  Tocolytics for delaying preterm birth: a network meta-analysis (0924).

Authors:  Amie Wilson; Victoria A Hodgetts-Morton; Ella J Marson; Alexandra D Markland; Eva Larkai; Argyro Papadopoulou; Arri Coomarasamy; Aurelio Tobias; Doris Chou; Olufemi T Oladapo; Malcolm J Price; Katie Morris; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2022-08-10

5.  Nicardipine-induced acute pulmonary edema: a rare but severe complication of tocolysis.

Authors:  Claire Serena; Emmanuelle Begot; Jérôme Cros; Charles Hodler; Anne Laure Fedou; Nathalie Nathan-Denizot; Marc Clavel
Journal:  Case Rep Crit Care       Date:  2014-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.